Related Experiment Video

Updated: Jun 20, 2025

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice
08:40

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

Published on: November 22, 2017

17.5K

Targeting cellular mitophagy as a strategy for human cancers

Yuming Dong1, Xue Zhang2

  • 1School of Stomatology, China Medical University, Shenyang, China.

Frontiers in Cell and Developmental Biology
|July 22, 2024
PubMed

Insights

Mitophagy, the process of clearing damaged mitochondria, is crucial for preventing tumor initiation and development. Understanding mitophagy mechanisms offers new avenues for anti-tumor therapies.

Area of Science:

  • Cellular Biology
  • Cancer Research
  • Mitochondrial Dynamics

Background:

  • Mitophagy selectively removes dysfunctional mitochondria, maintaining cellular health.
  • Dysregulated mitophagy contributes to tumor initiation and progression.
  • Mitophagy involves both ubiquitin-dependent (PINK1/Parkin) and independent pathways.

Purpose of the Study:

  • To review the molecular mechanisms of mitophagy.
  • To discuss the multifaceted role of mitophagy in various cancer contexts.
  • To highlight mitophagy as a potential anti-tumor therapeutic target.

Main Methods:

  • Literature review of mitophagy pathways.
  • Analysis of mitophagy's involvement in cellular processes relevant to cancer.
  • Synthesis of current understanding of mitophagy in tumor biology.

Main Results:

  • Mitophagy regulates key cellular processes including metabolism, immunity, ferroptosis, and tumor-microenvironment interactions.
  • Mitophagy influences tumor proliferation, metastasis, stemness, and resistance to therapies.
  • Both ubiquitin-dependent and independent mitophagy pathways are implicated in cancer.

Conclusions:

  • Mitophagy plays a complex, context-dependent role in tumorigenesis.
  • Targeting mitophagy presents a promising strategy for novel anti-tumor therapies.
  • Further research into mitophagy mechanisms can unlock new therapeutic potentials.
Keywords:
PINK1cancermitochondriamitophagystemness

More Related Videos

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome07:56

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome

Published on: November 30, 2022

4.4K
Author Spotlight: Detection of Mitophagy in Caenorhabditis elegans and Mammalian Cells Using Organelle-Specific Dyes11:59

Author Spotlight: Detection of Mitophagy in Caenorhabditis elegans and Mammalian Cells Using Organelle-Specific Dyes

Published on: May 19, 2023

2.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K